We performed IHC staining of tissue microarrays from 61 GBM patients (PN = 31 patients, MES = 10 patients, CL = 11 patients, unclassified = 9 patients) with antibodies against Olig2 and CD109 (Supplementary Fig. 1e). Here, CD109 is linked to glioblastoma.